Sunday, May 15, 2016
Pharma, The FDA, And Social Media
The pharmaceutical industry is beginning to embrace more communications and social channels. According to a recent study, since 2013, the average number of tweets by pharmaceutical companies has gone up by 530%. Top industry players have increased their Twitter followers by nearly 300%. Yet, although firms see the benefits, many are reluctant to wade into the social waters. With good reason. Without proper planning, controls and staff training, firms risk fines, sanctions and worse, damage to their reputation.